Literature DB >> 3651340

IgA anti-endomysial antibodies in dermatitis herpetiformis: correlation with jejunal morphology, gluten-free diet and anti-gliadin antibodies.

T Reunala1, T P Chorzelski, M Viander, J Sulej, E Vainio, V Kumar, E H Beutner.   

Abstract

Circulating IgA-class anti-endomysium antibodies (EmA) can be detected by indirect immunofluorescence on monkey oesophagus sections. We found EmA in 22 (76%) of 29 patients with dermatitis herpetiformis (DH) on a normal, gluten-containing diet. The highest frequency (100%) of EmA was observed in patients with sub-total villous atrophy. IgA-class antigliadin antibodies (AGA) were found using an ELISA method in 59% of 29 DH patients and in 86% of those with sub-total villous atrophy. There was a significant correlation between EmA titres and AGA levels in individual patients. Gluten-free diet (GFD) treatment caused a rapid decrease in EmA titres; only three of the 12 patients still showed raised EmA after 6-12 months on a GFD and two of these three had failed to adhere to a strict diet. In contrast, no decrease in EmA titres occurred in four patients maintained on a normal diet, and two of the three patients with initially negative EmA developed positive titres when continuing on a normal diet. These results show that both IgA-class EmA and AGA are good indicators of jejunal damage in DH. The rapid fall of EmA titres after gluten withdrawal indicates that this test is also useful for monitoring a patient's adherence to a GFD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3651340     DOI: 10.1111/j.1365-2133.1987.tb04115.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Autoantibodies and immunoglobulins in collagenous colitis.

Authors:  J Bohr; C Tysk; P Yang; D Danielsson; G Järnerot
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

2.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

3.  Tolerance to oats in dermatitis herpetiformis.

Authors:  T Reunala; P Collin; K Holm; P Pikkarainen; A Miettinen; N Vuolteenaho; M Mäki
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

Review 4.  Immunopathology and molecular diagnosis of autoimmune bullous diseases.

Authors:  Sidonia Mihai; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.